A large proportion of AMLs (81%) were classified into common subtypes: AML with KMT2A-r, PML::RARA, RUNX1::RUNX1T1, CBFB::MYH11, mutations (m) of GATA1, CEBPA or NPM1, respectively. This evidence concerns the gene RARA and acute myeloid leukemia.